Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases

By Ochs Hans   Gupta Sudhir   Kiessling Peter   Nicolay Uwe   Berger Melvin  

Journal of Clinical Immunology, Vol. 26, Iss. 3, 2006-05 ,pp. : 265-273

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

By Kanegane Hirokazu   Imai Kohsuke   Yamada Masafumi   Takada Hidetoshi   Ariga Tadashi   Bexon Martin   Rojavin Mikhail   Hu Wilson   Kobayashi Midori   Lawo John-Philip   Nonoyama Shigeaki   Hara Toshiro   Miyawaki Toshio  

Journal of Clinical Immunology, Vol. 34, Iss. 2, 2014-02 ,pp. : 204-211

Springer Publishing Company

Access to resources Recommend Favorite

Safety, Efficacy, and Pharmacokinetics of Flebogamma^® 5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases

By Berger Melvin   Pinciaro Paul J.    

Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. : 389-396

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

By Hagan John   Fasano Mary   Spector Sheldon   Wasserman Richard   Melamed Isaac   Rojavin Mikhail   Zenker Othmar   Orange Jordan  

Journal of Clinical Immunology, Vol. 30, Iss. 5, 2010-09 ,pp. : 734-745

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of Intravenous Immunoglobulin-Transmitted Hepatitis C Virus Infection in Primary Immunodeficiency

By Razvi S.   Schneider L.   Jonas M.M.   Cunningham-Rundles C.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 284-288

Academic Press

Access to resources Recommend Favorite